jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

July. 30, 2020

Sept. 01, 2020

jRCTs051200038

Development of a new cancer diagnostic method based on metabolites derived from samples before and after oral administration of 13C-labeled glucose in patients with PET-positive lung cancer : Single-arm, exploratory clinical trial

Search for new lung cancer biomarkers using 13C-labeled glucose

Yoshida Masaru

Kobe University Hospital

7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Hyogo

+81-78-382-6305

myoshida@med.kobe-u.ac.jp

Yoshida Masaru

Kobe University Hospital

7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Hyogo

+81-78-382-6305

myoshida@med.kobe-u.ac.jp

Complete

July. 30, 2020

Aug. 24, 2020
6

Interventional

single arm study

open(masking not used)

uncontrolled control

single assignment

diagnostic purpose

(1) Patients who are at least 20 years old and under 80 years old at the time of obtaining consent
(2) PET-positive primary lung cancer patients who can be surgically resected
(3) Patients who have given their informed consent to participate in this clinical study

(1) Patients with other cancers
(2) Other patients judged inappropriate by the person in charge of this clinical study

20age old over
80age old not

Both

Resectable primary lung cancer

Administration of 13C glucose

primary lung cancer

Identification of derived metabolites in blood and urine after 13C glucose administration

Whether or not adverse events have occurred

Kobe University Clinical Research Ethical Committee
7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Hyogo

+81-78-382-6669

cerb@med.kobe-u.ac.jp
Approval

June. 30, 2020

none

History of Changes

No Publication date
2 Sept. 01, 2020 (this page) Changes
1 July. 30, 2020 Detail